Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2017   |   Volume: 6   |   Issue: 1   |   Page: 116-118     View issue

Neoadjuvant chemotherapy in locally advanced cancers of oral cavity


, , , ,
Abstract

Oral cancers constitute a major burden of cancer in northeastern part of India. This can be attributed to the increased consumption of tobacco in various forms such as chewing, snuffing, powder or paste and smoking along with betel nut and areca nut. The majority of patients with oral cavity cancer present in an advanced stage which carries a poor prognosis. We present here a case of locally advanced (T4b) oral cavity cancer where 5-fluorouracil (5FU) and methotrexate (MTX) were used as neoadjuvant chemotherapy to attain a surgically resectable stage. The objective of this case report is to show the efficacy and impact of 5FU and MTX as induction chemotherapy in advanced oral cancers.

Cite this article
Vancouver
Das A, Kakati K, Baishya N, Roy P, Kataki A. Neoadjuvant chemotherapy in locally advanced cancers of oral cavity. Clin Cancer Investig J. 2017;6(1):116-8. https://doi.org/10.4103/ccij.ccij_128_16
APA
Das, A., Kakati, K., Baishya, N., Roy, P., & Kataki, A. (2017). Neoadjuvant chemotherapy in locally advanced cancers of oral cavity. Clinical Cancer Investigation Journal, 6(1), 116-118. https://doi.org/10.4103/ccij.ccij_128_16

© Clinical Cancer Investigation Journal
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513